Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dioscoreae Rhizoma, commonly known as Shanyao or Chinese yam, is the dried rhizome of *Dioscorea opposita* Thunb. (also classified as *Dioscorea polystachya*). It is a staple of Traditional Chinese Medicine (TCM) used to reinforce the spleen and stomach, promote fluid production, and benefit the lungs and kidneys. The herb contains a variety of bioactive compounds, including polysaccharides, steroid saponins (such as diosgenin), allantoin, and polyphenols. It has been clinically investigated for its potential in managing type 2 diabetes mellitus, diabetic neuropathy, and gastrointestinal disorders. In 2011, the Korean Food and Drug Administration (KFDA) approved a standardized extract of Dioscoreae Rhizoma for clinical use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dioscoreae rhizoma.